Citius Pharmaceuticals Inc (NASDAQ:CTXR)

1.32
Delayed Data
As of Jun 02
 +0.08 / +6.45%
Today’s Change
0.77
Today|||52-Week Range
1.71
+67.09%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +354.55% increase from the last price of 1.32.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Citius Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$0.00
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.29%
 
 
 
 
 
 
Growthannually 10.14%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.